C3is vs SVRN
CISS and SVRN side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CISS | SVRN |
|---|---|---|
| Size and price | ||
| Share price | $1.80 | $14.53 |
| Change, 1 year | −100.0% | −49.2% |
| Beta (5Y) | 0.41 | 1.01 |
| StockData Score | ||
| Total score | 7 | – |
| Valuation score | 0 | – |
| Growth score | 0 | – |
| Performance score | 2 | – |
| Health score | 5 | – |
| Dividend score | 0 | – |
| Growth | ||
| Revenue growth (TTM) | −17.8% | – |
| Profitability | ||
| Operating margin | 3.9% | – |
| Net margin | 30.1% | – |
| FCF margin | 11.0% | – |
| Return on equity | 11.1% | – |
| Return on invested capital | 1.1% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Current ratio | 1.68 | – |
| Piotroski F-score | 5 | – |
| Ownership | ||
| Held by institutions | 4.8% | 17.0% |
| Insider net buying, 12 months | – | $16.0K |
Go deeper
- CISS stock overview
- CISS income statement
- CISS valuation and score
- SVRN stock overview
- SVRN income statement
- SVRN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.